News & Press Releases
SET Announcements
16 Nov 2026
Invitation to propose agenda for the 2027 Annual General Meeting of Shareholder and Nominating Candidates for the Board of Director
Read the full announcement on the SET website ↗13 Nov 2026
Resignation of Director, Appointment of New Director, and Appointment of Chairman of the Audit Committee (Revised)
Read the full announcement on the SET website ↗13 Nov 2026
Notification of the Resolutions of the Board of Directors Regarding the Share Repurchase Project for Financial Management
Read the full announcement on the SET website ↗13 Nov 2026
Resignation of Director, Appointment of New Director, and Appointment of Chairman of the Audit Committee
Read the full announcement on the SET website ↗13 Nov 2026
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2026
Read the full announcement on the SET website ↗13 Nov 2026
Financial Performance Quarter 3 (F45) (Reviewed)
Read the full announcement on the SET website ↗13 Nov 2026
Financial Statement Quarter 3/2026 (Reviewed)
Read the full announcement on the SET website ↗27 Oct 2026
The Chairman of the Audit Committee and independent directors have resigned. (Revised)
Read the full announcement on the SET website ↗8 Sept 2026
Report on the results of the Exercise of MADAME-W6 (F53-5) (Revised)
On the exercise date of 26-Aug-2026, no MADAME-W6 warrants were exercised. Total unexercised warrants remain at 1,665,000,000 units. The number of shares remaining reserved from the warrants is 333,000,000 shares.
Summarised automatically from the announcement filed with SET.
Read the full announcement on the SET website ↗8 Sept 2026
Report on the results of the Exercise of MADAME-W6 (F53-5)
On 26-Aug-2026, no shares were derived from the exercise of MADAME-W6 warrants. The number of exercised warrants was 0 units, and the total unexercised warrants amount to 1,665,000,000 units.
Summarised automatically from the announcement filed with SET.
Read the full announcement on the SET website ↗11 Aug 2026
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026
Read the full announcement on the SET website ↗10 Aug 2026
Financial Performance Quarter 2 (F45) (Reviewed)
Read the full announcement on the SET website ↗10 Aug 2026
Financial Statement Quarter 2/2026 (Reviewed)
Read the full announcement on the SET website ↗31 Jul 2026
Report of the Utilization of Capital Increase
Read the full announcement on the SET website ↗6 Jul 2026
Establishment of a new joint venture company
Read the full announcement on the SET website ↗29 Jun 2026
Notification of the Completion of Registered Capital Reduction
Read the full announcement on the SET website ↗26 May 2026
Report on the results of the Exercise of MADAME-W6 (F53-5)
Read the full announcement on the SET website ↗21 May 2026
Notification convening date of the Public Presentation
Read the full announcement on the SET website ↗19 May 2026
Clarification Regarding the Securities and Exchange Commission's News Release No.104/2026 dated 18 May 2026
Read the full announcement on the SET website ↗15 May 2026
Financial Performance Quarter 1 (F45) (Reviewed) (Revised)
Read the full announcement on the SET website ↗15 May 2026
Financial Performance Quarter 1 (F45) (Reviewed)
Read the full announcement on the SET website ↗15 May 2026
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026
Read the full announcement on the SET website ↗15 May 2026
Financial Statement Quarter 1/2026 (Reviewed)
Read the full announcement on the SET website ↗28 Apr 2026
Notification of Change to the Company's Website
Read the full announcement on the SET website ↗30 Mar 2026
Publication of Invitation to the Annual General Meeting of Shareholders for the year 2026 with supporting documents.
Read the full announcement on the SET website ↗5 Mar 2026
Notification convening date of the Public Presentation
Read the full announcement on the SET website ↗4 Mar 2026
Report on the results of the Exercise of MADAME-W6 (F53-5) (Revised)
Read the full announcement on the SET website ↗27 Feb 2026
Notification of the resolution again, Meeting No. 2/2026, the omission of dividend payment, and the schedule of the Annual General Meeting of Shareholders for the year 2026 (Revised)
Read the full announcement on the SET website ↗27 Feb 2026
Financial Performance Yearly (F45) (Audited) (Revised)
Read the full announcement on the SET website ↗27 Feb 2026
Management Discussion and Analysis Yearly Ending 31 Dec 2025
Read the full announcement on the SET website ↗27 Feb 2026
Financial Performance Yearly (F45) (Audited)
Read the full announcement on the SET website ↗27 Feb 2026
Notification of the resolution again, Meeting No. 2/2026, the omission of dividend payment, and the schedule of the Annual General Meeting of Shareholders for the year 2026
Read the full announcement on the SET website ↗26 Feb 2026
Report on the results of the Exercise of MADAME-W6 (F53-5)
Read the full announcement on the SET website ↗10 Feb 2026
Notification on Completion of Registration for Adjustment of Par Value by Means of Reverse Stock Split (Share Consolidation), Amendment to Memorandum of Association and Compensation for Fraction of Shares after Adjustment of Par Value
Read the full announcement on the SET website ↗10 Feb 2026
Report on the results of sale of common shares offered to private placement (F53-5) (Revised)
Read the full announcement on the SET website ↗10 Feb 2026
Report on the results of sale of common shares offered to private placement (F53-5)
Read the full announcement on the SET website ↗6 Feb 2026
Notification of Registration of Increase of Registered Capital and Amendment to the Memorandum of Association of Madame Bioscience Public Company Limited
Read the full announcement on the SET website ↗5 Feb 2026
Notification of Registration of Decrease of Registered Capital and Amendment to the Memorandum of Association of Madame Bioscience Public Company Limited
Read the full announcement on the SET website ↗30 Jan 2026
Report of the Utilization of Capital Increase
Read the full announcement on the SET website ↗28 Jan 2026
Resolution of the Extraordinary General Meeting of Shareholders No. 1/2026
Read the full announcement on the SET website ↗28 Jan 2026
Announcement of the appointment of Directors, Executive Directors, Chairman of the Executive Board, and Chief Executive Officer.
Read the full announcement on the SET website ↗14 Jan 2026
Publication of the Invitation to the Extraordinary General Meeting of Shareholders No. 1/2026 along with supporting documents for the meeting
Read the full announcement on the SET website ↗26 Dec 2025
Notification of the Resolutions of the Board of Directors' Meeting No. 18/2025 regarding the Reduction of Capital, Increase of Capital, Change in Par Value of Shares, and the Determination of Date, Time, Venue, and Agenda for the EGM 1/2026 (Edited)
Read the full announcement on the SET website ↗26 Dec 2025
Notification of the Resolutions of the Board of Directors' Meeting No. 18/2025 regarding the Reduction of Capital, Increase of Capital, Change in Par Value of Shares, and the Determination of Date, Time, Venue, and Agenda for the EGM No. 1/2026
Read the full announcement on the SET website ↗18 Dec 2025
Notification of the Resolutions of the Board of Directors Meeting No. 17/2025 regarding the Disposal of Assets of a Subsidiary (Edited)
Read the full announcement on the SET website ↗17 Dec 2025